Improving TTD and supporting patient advocacy in CTCL

7 Views

08/09/23

Chalid Assaf, MD, PhD, Helios Klinikum Krefeld, Krefeld, Germany, highlights key areas of research in the field of cutaneous T-cell lymphoma (CTCL), in particular focusing on the need to reduce the time to diagnosis (TTD) and the importance of patient advocacy. This interview took place at the EORTC Cutaneous Lymphoma Group 20-21 meeting in Marseille.